PAR 0.00% 26.5¢ paradigm biopharmaceuticals limited..

PAR. SP, page-798

  1. 881 Posts.
    lightbulb Created with Sketch. 218
    When you say they're looking at all options to raise non-dilutive capital, but options are limited, it makes it seem that an MPS deal or a regional OA deal is unlikely even though it was indicated there would be some form of deal in the first 6 months of this year.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.